By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cellectar Biosciences (Formerly Known As Novelos Therapeutics, Inc.)  

3301 Agriculture Drive

Madison  Wisconsin  53716  U.S.A.
Phone: 608-441-8120 Fax: 608-441-8120


SEARCH JOBS


Industry
Pharmaceutical

Segment
Drug Discovery





Company News
Cellectar Biosciences  (NVLT) Reports Third Quarter 2014 Financial Results And Recent Highlights 11/12/2014 7:53:45 AM
Cellectar Biosciences  (NVLT) To Host Conference Call On November 11th To Discuss Third Quarter 2014 Results And Provide Quarterly Update On Development Progress 11/6/2014 1:13:37 PM
Cellectar Biosciences  (NVLT) Announces Publication Of Findings Demonstrating Efficacy Of Its Phospholipid Ether Analog Platform In Detecting Colorectal Cancer 10/15/2014 7:58:45 AM
Cellectar Biosciences  (NVLT) Announces Participation In Two Upcoming Investor Conferences In September 9/5/2014 8:01:16 AM
Cellectar Biosciences  (NVLT) Announces Acceptance Of Investigational New Drug Application To Evaluate I-131-CLR1404 In Clinical Trials In Relapsed Or Refractory Multiple Myeloma 9/4/2014 8:59:37 AM
Cellectar Biosciences  (NVLT) Reports Second Quarter 2014 Financial Results And Recent Highlights 8/21/2014 7:47:19 AM
Cellectar Biosciences  (NVLT) Announces Closing Of Public Offering And Partial Exercise Of Underwriter's Over-Allotment Option 8/21/2014 7:44:46 AM
Cellectar Biosciences  (NVLT) To Host Conference Call On August 20th To Discuss Second Quarter 2014 Results And Provide Quarterly Update On Development Progress 8/19/2014 6:55:27 AM
Cellectar Biosciences  (NVLT) Announces Pricing Of $12,500,000 Public Offering And Listing On The Nasdaq Capital Market 8/15/2014 7:51:47 AM
Cellectar Biosciences  (NVLT) Files Investigational New Drug Application To Evaluate I-131-CLR1404 In Clinical Trials In Relapsed Or Refractory Multiple Myeloma 8/11/2014 7:38:21 AM
12345678910...
//-->